[ad_1]
Craig Sable, MD, receives the 2018 Award for Meritorious Cardiovascular Disease (CVDY) from the American Heart Association
Washington Cardiologist Honored at 2018 Science Sessions for Accelerating Global Health Research Strategies
"In Uganda, an open heart operation costs between $ 5,000 and $ 10,000, while treating a child with penicillin for one year costs less than a dollar," says Dr. Sable. "Investing in prevention strategies is the best of all large-scale promises to eradicate rheumatic heart disease."
WASHINGTON (PRWEB) November 15, 2018
Craig Sable, MD, associate chief of the division of cardiology and director of echocardiography of the National Children's Health System, has won the award for excellence for all of his achievements, formerly the award of Meritorious Excellence for Cardiovascular Disease in 2018 Young People (CVDY), November 10th at Scientific Sessions of the American Heart Association 2018.
The CVDY Board awards this prestigious award to people with a significant impact in the field of cardiovascular disease in young people. The CVDY Board supports the mission to improve the health of children and adults with congenital heart disease and acquired heart disease during childhood through research, education, prevention and prevention. advocacy.
Dr. Sable is recognized for all of his research, training and advocacy work on congenital and acquired heart disease, but particularly for his research on rheumatic heart disease in Uganda.
Over the past 15 years, Dr. Sable has brought more than 100 doctors and medical staff to Kampala, Uganda's largest city and capital city, in partnership with more than 100 local doctors and clinicians to develop a model. sustainable infrastructure to diagnose, treat and prevent both congenital heart disease and congenital heart disease.
RHD is the result of damage to heart valves after acute rheumatic fever (ARF). The process begins with a sore throat caused by a strep infection, which many children in the United States treat with antibiotics.
"For patients who develop strep throat, their body's reaction to strep throat, in addition to resolution of its primary symptoms, can lead to heart attack," says Dr. Sable. "The initial damage is called rheumatic fever. In many cases, this disease is self-limiting, but if it is not detected, it can lead to long-term lesions of the heart valves, known as rheumatic heart disease, over the years. Unfortunately, once RH disease has been developed, the only treatment available is open heart surgery. "
In 2017, Sable and the researchers published a study in the New England Journal of Medicine on the global burden of RCM, often referred to as the disease of poverty.
RHD is more prevalent in low- and middle-income countries, as well as in marginalized communities in high-income countries. MDR has decreased globally but remains the leading cause of morbidity and mortality from heart disease in children and young adults around the world.
In 2017, there were 39.4 million RHD cases, resulting in 285,000 deaths and 9.4 million disability-adjusted life years.
In 2018, the World Health Organization released a referendum recognizing rheumatic heart disease as an important disease that member states and ministries of health must prioritize in their public health efforts.
The common denominator that drives Dr. Sable and international researchers, many of whom have received American Heart Association grants for the RHD study, is the impact that creating an evolutionary solution, such as widespread adoption vaccines, may have on whole communities.
"In Uganda, an open heart operation costs between $ 5,000 and $ 10,000, while treating a child with penicillin for one year costs less than a dollar," says Dr. Sable. "Investing in prevention strategies is the best of all large-scale promises to eradicate rheumatic heart disease."
Sand and the team have examined more than 100,000 children and are conducting the first randomized controlled trial involving nearly 1,000 children to examine the effectiveness of penicillin use to prevent progression of latent or subclinical heart disease, the earliest form of the disease.
During the Thanksgiving weekend, Dr. Sable and a team of surgeons will return to Uganda to operate on children affected by the disease, while advancing their research efforts to produce a scalable, export-friendly solution. global scale, to prevent early stage disease.
Dr. Sable and his colleagues around the world are collaborating on several research projects funded by grants. Over the next few years, the team hopes to answer several important questions, including: Does penicillin prevent the earliest form of AMD and can we develop a vaccine to prevent it?
To view previously published research by the team, visit Sable's PubMed profile.
To learn more about the global health initiatives led by researchers at Children's National, visit http://www.GHICN.org.
Media Contact: Jessica Frost | 301-828-7521 | 202-476-4500
Contact Author
National Children's Health System Jessica Frost
301-244-6721
Email> Visit the website
[ad_2]
Source link
